The Disease-Modifying Effects of Twice-Weekly Oral Azithromycin in Patients with Bronchiectasis
Authors:
- Michael A BauerMBMichael A Bauer
- Guy W. AmsdenGAGuy W. Amsden
- 1 January 2005
- journal article
- clinical trial
- Published by Springer Nature in Treatments in Respiratory Medicine
- Vol. 4 (2) , 117-122
Abstract
Introduction Bronchiectasis is a chronic pulmonary process characterized by recurrent respiratory infections leading to destruction of airways secondary to inflammation. We investigated whether the...Keywords
This publication has 21 references indexed in Scilit:
- BronchiectasisNew England Journal of Medicine, 2002
- Bronchial Inflammation and Colonization in Patients with Clinically Stable BronchiectasisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Erythromycin treatment in diffuse panbronchiolitisCurrent Opinion in Pulmonary Medicine, 1998
- Long-term azithromycin may improve lung function in children with cystic fibrosisThe Lancet, 1998
- Effect of Clarithromycin on Lymphocytes in Chronic Respiratory Pseudomonas Aeruginosa InfectionAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Interleukin 1β, Tumor Necrosis Factor Alpha, and Interleukin 8 in Bronchoalveolar Lavage Fluid of Patients with Diffuse Panbronchiolitis: A Potential Mechanism of Macrolide TherapyRespiration, 1996
- Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection.Thorax, 1995
- Clinical, Pathophysiologic, and Microbiologic Characterization of Bronchiectasis in an Aging CohortChest, 1995
- A Mechanism of Erythromycin Treatment in Patients with Diffuse PanbronchiolitisAmerican Review of Respiratory Disease, 1993
- Long-Term Low-Dose Administration of Erythromycin to Patients with Diffuse PanbronchiolitisRespiration, 1991